PositiveID Corporation (fka PSID)

[greaseyfingers]

Prior to the award of the BioWatch Gen-3 performance testing contract, the program must be reviewed again by the ARB to determine if the program is able to meet the revised targets in the program plan.

Conclusion

DHS has worked diligently to improve its acquisition processes and these efforts have produced more effective governance and significant improvements to future and current acquisitions. The BioWatch program is an example of the successful application of the Department’s improved acquisition oversight process. The program has accepted feedback from the Department and been open to revising strategies to ensure that risk is balanced against benefits. I will continue to evaluate the risk of this program in my role as the Department’s Chief Acquisition Officer and will only provide authorization to proceed when pre-established criteria are met.
While there is still much work to do, the Department has made significant strides to improve acquisition and investment management for the Department’s portfolio of major programs. I believe we are making progress to shifting the paradigm so investment decisions are more empirically driven and there is qualified technical expertise to support program managers at each phase of the life cycle.
http://homeland.house.gov/sites/homeland.house.gov/files/Testimony%20Borras_1.pdf


Robsct Sunday, December 30, 2012 12:13:44 PM
Re: greaseyfingers post# 2949 Post #2950 of 2952

greasey...so what's your point? You're saying we should all run from PSID? Why are you here?